| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $32.02M | - | |
| CFO | 90.3K | $7.34M | - | |
| Other | 80.1K | $6.51M | - | |
| VP | 79.1K | $6.43M | - | |
| Other | 72.7K | $5.91M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | Pauwels Eric62 | Chief Business Officer | Sell | 11,220 | $56.16 | $630,104.40 | -2.9% | -9.3% | +18.0% | |
| Mar 13, 2025 | Okey Stephanie56 | Director | Sell | 5,000 | $54.00 | $270,000.00 | -36.1% | -3.7% | +22.2% | |
| Mar 12, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 15,521 | $53.30 | $827,232.91 | -7.0% | -3.5% | +18.2% | |
| Mar 11, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 75,420 | $53.08 | $4,003,304.97 | -10.7% | -1.7% | +24.9% | |
| Mar 4, 2025 | Jacobson Allan Steven51 | Director | Sell | 1,230 | $51.52 | $63,369.60 | -6.0% | -5.7% | +24.1% | |
| Feb 20, 2025 | Pauwels Eric62 | Chief Executive Officer | Sell | 2,945 | $50.11 | $147,576.60 | -1.7% | -8.3% | +40.3% | |
| Feb 20, 2025 | Boulding Mark Elliott55 | Exec. VP And CLO | Sell | 2,947 | $50.11 | $147,678.10 | -1.4% | -8.3% | +40.3% | |
| Feb 20, 2025 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 2,946 | $50.11 | $147,627.95 | -1.4% | -8.3% | +40.3% | |
| Feb 20, 2025 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell | 1,757 | $50.11 | $88,043.26 | -1.4% | -8.3% | +40.3% | |
| Feb 20, 2025 | Gravier Pierre55 | Chief Financial Officer | Sell | 2,335 | $50.11 | $117,006.84 | -1.5% | -8.3% | +40.3% |